Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

With a strong presence in Canada, Australia and New Zealand, Sandoz is committed to helping millions of patients access critical and potentially life-changing biologic medicines sustainably and ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of ...

Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.

ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ...

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

The authors noted that this is the first prospective case series to apply a structured, protocol-based approach to ...

Imran has been imprisoned since August 2023, currently serving a sentence at Adiala Jail in a £190 million corruption case.

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...

To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...

In recent years, we’ve seen the emergence of the second-generation anti-angiogenics as the gold standard for treating wet AMD. We’ve seen incredible success, I would say, one of the biggest successes ...

Belite Bio (BLTE) stock outlook: tinlarebant clinical data, 2026 filings, key FDA/EU risks, and $165/share valuation. See if ...